Clinical Trial Update: 3-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent Implantation

View source ↗

Summary

This clinical trial update discusses discontinuation of dual antiplatelet therapy at 3 months after Ultimaster sirolimus-eluting stent implantation in patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Teikyo University | Conditions: Coronary Artery Disease | Status: UNKNOWN